HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis

Tissue Antigens

Volumn 49, Issue 2, 1997, Pages 116-123

  Gonzalez Roces, S ^a   Alvarez, M V ^a   Gonzalez, S ^a   Dieye, A ^b   Makni, H ^c   Woodfield, D G ^d   Housan, L ^e   Konenkov, V ^f   Abbadi, M C ^g   Grunnet, N ^h   Coto, E ^a   Lopez Larrea C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c UNIVERSITY OF SFAX   (Tunisia)

^d Auckland Regional Blood Bank ^*  (New Zealand)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^g Institut Pasteur d'Algerie   (Algeria)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ankylosing spondylitis; Arthritogenic peptide; B27 alleles; HLA and disease association

Indexed keywords

HLA B27 ANTIGEN;

ALLELE; AMERICAN INDIAN; ANKYLOSING SPONDYLITIS; ARAB; ARTICLE; ASIAN; CAUCASIAN; CHINA; GENE MAPPING; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; JEW; MAJOR CLINICAL STUDY; MIDDLE EAST; NORTH AFRICA; POLYMERASE CHAIN REACTION; POLYNESIA; POPULATION GENETICS; PRIORITY JOURNAL; THAILAND;

THAIS;

EID: 0013579017     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02724.x     Document Type: Article

References (36)

1. López de Castro JA. Structural polymorphism and function of HLA-B27. Curr Opin Rheumatol 1995: 7:270-278.
2. Khan MA. Spondyloarthropathies - spondyloarthropathies. Curr Opin Rheumatol 1996: 8: 267-268.
3. Hasegawa T, Sugahara Y, Moriyama Y et al. A new HLA-B27 allele found in a healthy Japanese. Hum Immunol 1996: 47: 8 (abstr).
4. Choo SY, John TS, Orr HT, Hansen JA. Molecular analysis of the variant alloantigen HLA-B27d (B*2703) identifies a unique single amino acid substitution. Hum Immunol 1988: 21: 209-219.
5. López de Castro JA. HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 1989: 10: 239-246.
6. Choo SY, Fan Lian, Hansen JA. A novel HLA-B27 allele maps B27 allospecificity to the region around position in the alphal domain. J Immunol 1991: 147: 174-80.
7. Del Porto P, D'Amato M, Fiorillo MT, Tuosto L, Piccolella E, Sorrentino R. Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic γδ. J Immunol 1994: 153: 3093-3100.
8. Vilches C, de Pablo R, Kreisler M. Nucleotide sequence of HLA-B*2706. Immunogenetics 1994: 39: 219.
9. Rudwaleit M, Bowness P, Wordsworth P. The nucleotide sequence of HLA-B*2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B*2706. Immunogenetics 1996: 43: 160-162.
10. Breuning MH, Lucas CJ, Breur BS et al. Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self recognition. Hum Immunol 1982: 5: 259-268.
11. Choo SY, Antonelli P, Nisperos B, Nepon GT, Hansen JA. Six variants of HLA-B27 identified by isoelectric-focusing. Immunogenetics 1986: 23: 24-29.
12. Reekers P, Tiilikainen A, Darke C, Van der Horst A, McCloskey D. Antigen Society no. 111, part 2: HLA-B7-like antigens (B703(BPOT), B7Qui, BDT, B7SL, B7x40, BRI, B41V. In: Vol. 1, HLA 1991. Oxford: Oxford Science Publications, 1992: 327-330.
13. Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987: 46: 353-356.
14. López-Larrea C, Gonzalez-Roces S, Peña M et al. Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis. Hum Immunol 1995: 43: 174-180.
15. Ivanyi P. Immunogenetic basis of the seronegative spondyloarthropathies. Curr Opin Rheumatol 1992: 4: 484-493.
16. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African subtype. Lancet 1991: 337: 640-642.
17. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995: 7: 263-269.
18. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991, Vol. 1. Oxford: Oxford University Press, 1992: 1065.
19. Choo SY. The HLA-B27 antigen family and disease susceptibility. In: Molecular mimicry in HLA-B27 related arthritis. Ann Intern Med 1989: 111: 581-591.
20. López-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Tissue Antigens 1995: 45: 169-176.
21. MacLean I. HLA-B27 subtypes: implications for the spondyloarthropathies. Ann Rheum Dis 1992: 51: 929-931.
22. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995: 25: 3199-3201.
23. Nasution AR, Mardjuadi A, Kunmartini S et al. B27 subtypes and their association with ankylosing spondylitis. Abstract (No. 176) of the 16th European Workshop for Rheumatology Research, 1996.
24. Hermann E, Yu DT, Meyer zum Buschenfelde HM, Fleischer B. HLA-B27-restricted CDS T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993: 342: 646-646.
25. Buxton SE, Benjamin RJ, Clayberger C, Parham P, Krensky AM. Anchoring pockets in human histocompatibility complex leucocyte antigen (HLA) class I molecules: analysis of the conserved B′45′ pocket of HLA-B27. J Exp Med 1992: 175: 809-819.
26. Dougados M, van der Linden S, Juhlin R et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of Spondyloarthropathy. Arthritis Rheum 1991: 34: 1218-1227.
27. Gonzalez-Roces S, Brautbar C, Peña M et al. Molecular analysis of HLA-B27 haplotypes in Caucasoids: Frequencies of HLA-B27/HLA-Cw in Jewish and Spanish populations. Hum Immunol 1994: 41: 127-134.
28. Dominguez O, Coto E, Martinez-Naves E, Choo SY, López-Larrea C. Molecular typing of HLA-B27 alleles. Immunogenetics 1992: 36: 277-282.
29. Sanger F, Niklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977: 74: 5463-5467.
30. Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton: Princeton University Press, 1994.
31. Daser A, Urlaub H, Henklein P. HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules. Mol Immunol 1994: 31: 331-336.
32. Lyashko VN, Vikulova VK, Chernicov VG et al. Comparison of the heat shock response in ethnically and ecologically different human populations. Proc Natl Acad Sci USA 1994: 91: 12492-12495.
33. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990: 11: 137-142.
34. Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 1993: 178: 879-887.
35. Villadangos JA, Galocha B, García-Hoyo R, López D, García F, López de Castro JA. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited to a subset of the antigenic determinants B*2705. Eur J Immunol 1994: 24: 2548-2555.
36. Rovero P, Riganelli D, Fruci D et al. The importance of secondary anchor residue motifs of HLA class I proteins: a chemometric approach. Mol Immunol 1994: 31: 549-554.